Antiphospholipid antibodies can increase risk for thrombosis in pregnant women and have been associated with adverse pregnancy outcomes.1-3 Indeed, clinical criteria that can be used to diagnose APS include several pregnancy-related morbidities, such as unexplained recurrent miscarriage, unexplained fetal death, and severe pre-eclampsia leading to preterm birth.1-3
Importantly, these clinical manifestations can have many underlying causes and should be assessed with accompanying laboratory diagnostics to determine if APS is a potential etiological factor.1